Gene Therapy Of The Human Retina Stocks List

	Symbol	Grade	Name	% Change
	FDMT	D	4D Molecular Therapeutics, Inc.	1.90
	ADVM	F	Adverum Biotechnologies, Inc.	1.70

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
MOON	F	Direxion Moonshot Innovators ETF	4.07
HELX	D	Franklin Genomic Advancements ETF	1.45
BBC	D	Virtus LifeSci Biotech Clinical Trials ETF	1.26
IDNA	D	iShares Genomics Immunology and Healthcare ETF	1.25
SBIO	D	ALPS Medical Breakthroughs ETF	0.9

Compare ETFs

Date	Stock	Title
Apr 19	ADVM	Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Apr 18	FDMT	To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Apr 15	FDMT	4D Molecular Therapeutics new overweight at Barclays on genetic medicine platform

Gene Therapy Of The Human Retina: Gene therapy of the human retina is a form of gene therapy that involves introducing healthy genes into the cells of the retina in order to treat or prevent certain diseases or disorders of the eye. This type of therapy is used to treat conditions such as retinitis pigmentosa, age-related macular degeneration, and Leber congenital amaurosis. The goal of gene therapy is to replace the defective gene with a healthy gene, allowing the cells of the retina to function normally.